Biodistribution study of Ethiodized Oil Emulsion 13 for computed tomography of the liver and spleen.
Biodistribution studies were conducted with a new intravenous lipoid contrast material currently undergoing clinical trials in four hospitals. The contrast material selectively opacifies the liver and spleen for computed tomographic examination. The experiments were performed on rats with 125I-labeled ethiodized oil emulsion. The study showed that the liver accumulates nearly 80% of the injected iodine within 15 min of the injection and retains a high concentration over 3 h. The second highest concentration was found in the spleen. More than 99% of the iodine is eliminated from the liver and spleen within 48 h, primarily through the kidneys.
D000818:Animals; D003110:Colonic Neoplasms / Q000000981:diagnostic imaging; D003287:Contrast Media / Q000378:metabolism*; D004998:Ethiodized Oil / Q000378:metabolism*; D006801:Humans; D007457:Iodine Radioisotopes; D008099:Liver / Q000000981:diagnostic imaging*; D008113:Liver Neoplasms / Q000000981:diagnostic imaging / Q000556:secondary; D051381:Rats; D011919:Rats, Inbred Strains; D013154:Spleen / Q000000981:diagnostic imaging*; D013961:Thyroid Gland / Q000378:metabolism; D013997:Time Factors; D014018:Tissue Distribution; D014057:Tomography, X-Ray Computed / Q000379:methods*
D003287:Contrast Media; D007457:Iodine Radioisotopes; D004998:Ethiodized Oil